• Latest Posts

A New Vaccine Against Pneumonia and Meningitis Reaches Human Trials..

Peanut Allergies? This Phase III Trial Could Mean an End to Nut-Related Anaphylaxis

“Structural Biology is changing the way we design drugs”

Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?

CAR-T Phase II: 93% Complete Remission in Children with Relapsed Leukemia!

ADVERTISEMENT

Here are the 6 Healthcare Disruptors We met in Paris

Merck Pulls out of Plans to Commercialize Cancer Drug After it Fails in Two Phase III Trials

Best-in-Class Label for Blood Cancer Trial by Billion Euro Biotech

Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons

What Happened this week? Cellectis’ CEO, Rare Disease, CRISPR

Black Friday Ruin as TWO Biotechs Fail in Phase III Trials

ADVERTISEMENT